Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Kommissionsgebühren: sgv begrüsst Einigung des Preisüberwachers mit Worldline (Moneycab) +++ WORLDLINE Aktie +4,55%

ORTHOPEDIATRICS Aktie

>ORTHOPEDIATRICS Performance
1 Woche: 0%
1 Monat: -7,5%
3 Monate: -20,9%
6 Monate: -14,4%
1 Jahr: -32,0%
laufendes Jahr: -15,1%
>ORTHOPEDIATRICS Aktie
Name:  ORTHOPEDIATRICS DL-,00025
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US68752L1008 / A2JAAV
Symbol/ Ticker:  2X7 (Frankfurt) / KIDS (NASDAQ)
Kürzel:  FRA:2X7, ETR:2X7, 2X7:GR, NASDAQ:KIDS
Index:  -
Webseite:  http://www.orthopediatric..
Marktkapitalisierung:  636.48 Mio. EUR
Umsatz:  183.94 Mio. EUR
EBITDA:  -10.08 Mio. EUR
Gewinn je Aktie:  -1.325 EUR
Schulden:  69.16 Mio. EUR
Liquide Mittel:  50.88 Mio. EUR
Umsatz-/ Gewinnwachstum:  17.3% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  2.34 / 1.53 / -
Gewinnm./ Eigenkapitalr.:  -19.15% / -11.34%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  ORTHOPEDIATRICS
Letzte Datenerhebung:  25.06.25
>Eigentümer
Aktien: 24.77 Mio. St.
f.h. Aktien: 16.57 Mio. St.
Insider Eigner: 33.09%
Instit. Eigner: 71.16%
>Peer Group

 
14.05.25 - 13:03
 OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting (GlobeNewswire EN)
 
Reinforced Long-Term Commitment as Emerald Sponsor Reinforced Long-Term Commitment as Emerald Sponsor...
08.05.25 - 01:00
 OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
 
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -50% and 1.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...
08.04.25 - 14:09
 OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System (GlobeNewswire EN)
 
WARSAW, Ind., April 08, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat Early Onset Scoliosis (“EOS”). This represents the company's 80th system designed to treat musculoskeletal issues in children....
25.03.25 - 21:06
 OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire EN)
 
WARSAW, Ind., March 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference....
24.03.25 - 21:09
 OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana (GlobeNewswire EN)
 
WARSAW, Ind., March 24, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was selected as one of the 2025 Best Places to Work in Indiana. This is the 9th time the Company has been recognized by the annual program created by the Indiana Chamber of Commerce....
21.03.25 - 20:45
 Demystifying OrthoPediatrics: Insights From 4 Analyst Reviews (Benzinga)
 
Latest Ratings for KIDS DateFirmActionFromTo Mar 2022NeedhamMaintainsBuy Dec 2021BTIGMaintainsBuy Dec 2021Truist SecuritiesMaintainsBuy View More Analyst Ratings for KIDS View the Latest Analyst Ratings read more...
19.03.25 - 05:01
 Insiderhandel: Pres. Trauma & Def. Correction verkauft Aktien von Orthopediatrics im Wert von 131758 USD (Insiderkauf)
 
Hauser, Joseph W. - Vorstand - Tag der Transaktion: 2025-03-18...
19.03.25 - 05:01
 Insiderhandel: General Counsel and Secretary verkauft Aktien von Orthopediatrics im Wert von 132007 USD (Insiderkauf)
 
Gerritzen, Daniel J. - Vorstand - Tag der Transaktion: 2025-03-18...
19.03.25 - 05:01
 Insiderhandel: President of Scoliosis verkauft Aktien von Orthopediatrics im Wert von 133225 USD (Insiderkauf)
 
Odle, Gregory A. - Vorstand - Tag der Transaktion: 2025-03-18...
19.03.25 - 05:01
 Insiderhandel: COO and CFO verkauft Aktien von Orthopediatrics im Wert von 160173 USD (Insiderkauf)
 
Hite, Fred - Vorstand - Tag der Transaktion: 2025-03-18...
19.03.25 - 05:01
 Insiderhandel: President and CEO verkauft Aktien von Orthopediatrics im Wert von 164573 USD (Insiderkauf)
 
Bailey, David R. - Vorstand - Tag der Transaktion: 2025-03-18...
17.03.25 - 21:09
 OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation (GlobeNewswire EN)
 
WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company's cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.​...
05.03.25 - 01:45
 Compared to Estimates, OrthoPediatrics (KIDS) Q4 Earnings: A Look at Key Metrics (Zacks)
 
While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
05.03.25 - 01:00
 OrthoPediatrics (KIDS) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
 
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -31.82% and 0.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...
04.03.25 - 22:18
 OrthoPediatrics GAAP EPS of -$0.69 misses by $0.38, revenue of $52.7M beats by $1.54M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.02.25 - 14:06
 OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 (GlobeNewswire EN)
 
WARSAW, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, March 4, 2025 at 4:30 p.m. ET to discuss the results....
22.01.25 - 14:09
 OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC (GlobeNewswire EN)
 
WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing solutions to the US market through its OrthoPediatrics Specialty Bracing (OPSB) division....
13.01.25 - 22:18
 OrthoPediatrics reports preliminary FY 2024 net revenue of $204.7 million (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.01.25 - 22:03
 OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance (GlobeNewswire EN)
 
Achieves all-time high full year 2024 Revenue of $205 million representing growth of 38% Year-Over-YearInitiates guidance for record adjusted EBITDA in 2025...
10.01.25 - 14:09
 OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division (GlobeNewswire EN)
 
WARSAW, Ind., Jan. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the rapid expansion of its Specialty Bracing (OPSB) division with entrance into 3 target markets within Indiana, Colorado, and Florida. ...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wenn man Geld richtig behandelt, ist es wie ein Hund, der einem nachläuft. - Howard Hughes
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!